Disc Medicine Inc Corporate Call at EHA Transcript
Ladies and gentlemen, thank you for standing by and welcome to the Disc Medicine Corporate Call at EHA 2026. (Operator Instructions) Please be advised that today's conference is being recorded.
I would like now to turn the conference over to John Quisel, Chief Executive Officer. Please go ahead.
Good morning and welcome to the Disc Medicine Management Call. This is John Quisel speaking, CEO here at Disc, and I will be joined by Will Savage, our Chief Medical Officer; and Jonathan Yu, our Chief Operating Officer.
To review the data presented at the European Hematology Association Conference in Stockholm this past weekend, as well as data from our oral presentation at ASCO earlier in the month.
Before we get started, I'll cover a few preliminaries. We will be making forward-looking statements and these should be taken in context with respect to materials that we have filed with the SEC and have posted on our website.
Additionally, bitopertin DISC-0974 and DISC-3405 are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
